| BSE: 531210 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE923C01011 |
| BSE 00:00 | 01 Apr | 6.19 |
0 (0.00%) |
OPEN
6.19 |
HIGH
6.19 |
LOW
6.19 |
| NSE 05:30 | 01 Jan | Colinz Laboratories Ltd |
| OPEN | 6.19 |
| PREVIOUS CLOSE | 6.19 |
| VOLUME | 2 |
| 52-Week high | 13.60 |
| 52-Week low | 6.19 |
| P/E | 11.68 |
| Mkt Cap.(Rs cr) | 3 |
| Buy Price | 6.19 |
| Buy Qty | 1.00 |
| Sell Price | 7.19 |
| Sell Qty | 300.00 |
8.50 am | 25 Apr 2019 | Business Standard
Here's a look at the top stocks that may remain in focus today -
11.31 am | 24 Apr 2019 | Business Standard
At the higher end of the issue price of Rs 215 a share, the stock is valued at nearly 20.1x FY18 EV/EBITDA and nearly 47.8x P/E
6.32 am | 24 Apr 2019 | Business Standard
Nifty outlook and top trading ideas by Vaishali Parekh, research analyst - technical research at Prabhudas Lilladher.
1.23 am | 24 Apr 2019 | Business Standard
Strong demand for active ingredients is further accentuated by shortages even as prospects in custom synthesis business remain firm
1.04 am | 24 Apr 2019 | Press Trust of India
The Mumbai-based drug maker, however, said it does not believe that the classification would have an impact on disruption of supplies or the existing ...
9.25 pm | 23 Apr 2019 | Business Standard
Sources said the company got approval earlier this month for generic Clopidogrel, which is used primarily to prevent blood clotting and acts against c...
9.11 pm | 23 Apr 2019 | Business Standard
Flags increased risk in wholesale lending; may impact asset quality going forward
4.04 pm | 23 Apr 2019 | Business Standard
Lupin gained 5 per cent to Rs 869 in intra-day deal today, after Morgan Stanley upgraded the stock to 'overweight' from 'equal-weight' rating.
4.04 pm | 23 Apr 2019 | Business Standard
Lupin gained 5 per cent to Rs 869 in intra-day deal today, after Morgan Stanley upgraded the stock to 'overweight' from 'equal-weight' rating.
4.04 pm | 23 Apr 2019 | Business Standard
Lupin gained 5 per cent to Rs 869 in intra-day deal today, after Morgan Stanley upgraded the stock to 'overweight' from 'equal-weight' rating.
9.58 am | 23 Apr 2019 | Business Standard
A successful Golden Cross not only changes the stock sentiment but adds to the immediate trading strategies. One may look at going long, considering 1...
10.32 pm | 22 Apr 2019 | Business Standard
Division bench says court will hear Bayer if the export by the two companies is done for purposes other than research
11.57 am | 21 Apr 2019 | Press Trust of India
CGMP refers to the Current Good Manufacturing Practice regulations enforced by the USFDA
12.35 am | 17 Apr 2019 | Business Standard
Price cuts, a higher share of exports have led to a revision of margin estimates
10.08 am | 16 Apr 2019 | Business Standard
On Monday, the stock of Metropolis Healthcare, a diagnostics company, settled nine per cent higher compared to the issue price on its stock market deb...
8.15 am | 16 Apr 2019 | Business Standard
Nifty outlook and top trading ideas by Jay Anand Thakkar, CMT - Assistant Vice President - Equity Research, Anand Rathi Shares and Stock Brokers.
12.32 am | 16 Apr 2019 | Business Standard
Firm is adding volume-driven products such as the recent acquisition of 42 ANDAs. The portfolio has over 30 injectables and an addressable market size...
9.43 pm | 15 Apr 2019 | Business Standard
During the previous quarter too, the Indian drug firms had reported a better than expected performance in the US
9.43 pm | 15 Apr 2019 | Business Standard
During the previous quarter too, the Indian drug firms had reported a better than expected performance in the US
4.11 pm | 15 Apr 2019 | Business Standard
The public issue of the company was subscribed 5.84 times, as per subscription data available on exchanges.
